- Home
- SBFM vs POLA Comparison
SBFM vs POLA Comparison
Compare SBFM & POLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SBFM
- POLA
- Stock Information
- Founded
- SBFM 2006
- POLA 1979
- Country
- SBFM United States
- POLA United States
- Employees
- SBFM N/A
- POLA N/A
- Industry
- SBFM Biotechnology: Pharmaceutical Preparations
- POLA Industrial Machinery/Components
- Sector
- SBFM Health Care
- POLA Miscellaneous
- Exchange
- SBFM Nasdaq
- POLA Nasdaq
- Market Cap
- SBFM 4.9M
- POLA 5.6M
- IPO Year
- SBFM N/A
- POLA 2016
- Fundamental
- Price
- SBFM $1.55
- POLA $2.10
- Analyst Decision
- SBFM Strong Buy
- POLA
- Analyst Count
- SBFM 1
- POLA 0
- Target Price
- SBFM $15.00
- POLA N/A
- AVG Volume (30 Days)
- SBFM 4.3M
- POLA 15.9K
- Earning Date
- SBFM 05-19-2025
- POLA 05-14-2025
- Dividend Yield
- SBFM N/A
- POLA N/A
- EPS Growth
- SBFM N/A
- POLA N/A
- EPS
- SBFM N/A
- POLA N/A
- Revenue
- SBFM $34,874,283.00
- POLA $13,970,000.00
- Revenue This Year
- SBFM $192.48
- POLA N/A
- Revenue Next Year
- SBFM N/A
- POLA N/A
- P/E Ratio
- SBFM N/A
- POLA N/A
- Revenue Growth
- SBFM 44.75
- POLA N/A
- 52 Week Low
- SBFM $1.17
- POLA $1.78
- 52 Week High
- SBFM $33.60
- POLA $4.90
- Technical
- Relative Strength Index (RSI)
- SBFM 44.81
- POLA 40.75
- Support Level
- SBFM $1.17
- POLA $2.02
- Resistance Level
- SBFM $1.59
- POLA $2.27
- Average True Range (ATR)
- SBFM 0.19
- POLA 0.15
- MACD
- SBFM 0.03
- POLA 0.02
- Stochastic Oscillator
- SBFM 52.84
- POLA 54.33
About SBFM Sunshine Biopharma Inc.
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
About POLA Polar Power Inc.
Polar Power Inc is engaged in designing, manufacturing, and selling DC power generators, renewable energy, and cooling systems for applications in the telecommunications market and, to a lesser extent, in other markets, including military, electric vehicle, marine, and industrial. The company's products include DC generators, backup DC generators, hybrid power systems, Li-Ion battery systems, Marine DC generators, and others. The company's geographical presence is in the United States, Canada, Australia and South Pacific Islands, Asia, Europe and Middle East, United Kingdom, Other North America, South Africa, and others.